New stem cell implants can now produce dopamine inside a patient's brain
Innovative clinical trials have successfully used stem-cell-derived neurons to replace lost dopamine-producing cells in the human brain, offering a potential breakthrough for long-term Parkinson’s disease management.
Researchers have successfully implanted stem-cell-derived neurons into the brains of Parkinson’s patients to restore natural dopamine production. In a landmark 2023 study, these lab-grown cells successfully integrated into the nervous system, significantly reducing motor symptoms for participants. This approach targets the root cause of the disease rather than just masking symptoms with temporary medication.
There's more to this story — open the app to keep reading.
Continue Reading in App
1 more paragraphs · plus a 2-question quiz